E.g., 11/19/2019
E.g., 11/19/2019
Title Category Credit Event date Pricesort descending
Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment Webcast (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary AUA Castration-Resistant Prostate Cancer Guideline Amendment webcast.
Highlights from AUA2019: Evolving Role of the Urologist in Metastatic and Castration Resistant Prostate Cancer (2019) $0.00 The AUA is launching an educational initiative to focus on resident and fellow training in the area of Advanced and Castration-Resistant Prostate Cancer. Based on the documented need for additional education in this area, the AUA has developed multiple educational interventions to improve the ability to care for patients with CRPC. These educational activities may also be of interest to advanced practice providers and urologists.
Emerging Treatment Options for Non-Metastatic CRPC Podcast (2018)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary Emerging Treatment Options for Non-Metastatic CRPC Podcast (2018).
Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Webcast (2018)
    • 7.75 AMA PRA Category 1 Credit™
    • 7.75 Non-Physician Participation
$0.00 Urologists continue to indicate one of the greatest educational needs in integrating systemic agents into the management of advanced prostate cancer. With numerous new treatments now available to urologists to manage advanced disease, sequencing and managing the side effects of each treatment have become increasingly important.
Active Surveillance for Prostate Cancer (2019)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Active surveillance is the recommended management for low-risk prostate cancer but is currently underutilized. This course includes five modules about active surveillance for prostate cancer, with a target audience of urologists, trainees and allied health professionals.
Update Series (2015) Lesson 4: Natural Medicine for Early Prostate Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
AUA Annual Meeting Highlights (2019): Prostate Cancer
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Non-Physician Participation
$0.00 To better understand urologists’ educational needs for treating CRPC, the AUA conducted an in-depth educational needs assessment of its domestic membership representing >90% of U.S. Board Certified urologists in 2013 (Phase I). The AUA reassessed its member’s educational needs after releasing the updated CRPC Guideline and targeted CRPC educational activities in 2015 (Phase II) and again in 2017 (Phase III).
Update Series (2015) Lesson 24: Preventive Medicine Counseling in the Urologist’s Office $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer Highlights (2018)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Urologists continue to indicate one of the greatest educational needs in integrating systemic agents into the management of advanced prostate cancer. With numerous new treatments now available to urologists to manage advanced disease, sequencing and managing the side effects of each treatment have become increasingly important.
Evolving Role of the Urologist in Metastatic and Castration Resistant Prostate Cancer: A Guidelines and Case-Based Discussion - Washington, D.C. (...
    • 5.75 AMA PRA Category 1 Credit™
    • 5.75 Non-Physician Participation
12/03/2019 $0.00 Presented by the AUA in partnership with the Society of Urologic Oncology (SUO).
Update Series (2015) Lesson 29: Contemporary Management of Advanced Prostate Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2015) Lesson 35: High Grade Prostatic Intraepithelial Neoplasia: Natural History and Management $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Immuno-Oncology: A Focus on Prostate Cancer Webcast (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. This is the fourth in a series of 4 webinars.
Update Series (2019) Lesson 2: Evaluation and Management of Posterior Urethral Stenosis after Prostate Cancer Therapy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 
Treatment for Metastatic Hormone Sensitive Prostate Cancer (M-HSPC) Podcast (2019)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.

Pages